You are here

Pharmaceuticals and Healthcare

The business of vital innovation

Share

The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience

Achilles Vaccines

assisting leading Italian vaccine-developer Achilles Vaccines on various projects, including the creation of a platform for streamlining the research and development of new vaccines (including against COVID-19) and the start of a collaboration with vAMRes Lab at Toscana Life Sciences (TLS) Foundation (based in Siena, Italy) on a research project for the development of human monoclonal antibodies against COVID-19, with the aim of using them for prophylactic/therapeutic purposes and as molecular baits for the discovery of vaccine antigens. We also advised on Italian and German finance, IP and regulatory aspects of its EUR 46 million venture loan financing from EMF EU Malaria Fund (a fund linked to EIB)

Abbvie Inc.

Advising Abbvie Inc., on the EU merger control aspects of its US$63 billion acquisition of Allergan

Sterling Pharma Solutions

Advising Sterling Pharma Solutions on its disposal of a UK based pharmaceutical manufacturing business by way of auction sale to GHO Capital

Abcam Plc

Advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business for €120m

Lupin Limited

Advising Lupin, on the sale of its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., Ltd. (Kyowa), to Unison Capital for JPY 57.4 billion (c.US$525 million)

Strides Pharma Science Limited

Advising Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AU$394 million sale of its entire Australian business, including Arrow Pharmaceuticals, to Arrotex

Insights and updates

18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...
24th June 2021
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension...
21st June 2021
As Australia moves to liberalise oversight of mobile health apps, we ask if such reforms...
26th May 2021
The Australian Consumer Law marked its tenth anniversary on 1 January 2021. Some belated presents...

Related news and deals

23 December 2021

Herbert Smith Freehills advises sole sponsor on Shanghai Bio-heart's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人律师为百心安香港IPO提供法律服务

10 November 2021

Kewei adds corporate senior consultant Angela Zhao to China joint operation with Herbert Smith Freehills 科伟律师事务所迎来公司事务资深顾问赵秋丹 加入与史密夫斐尔联营办公室

15 October 2021

Herbert Smith Freehills advises sponsors on Abbisko’s HK$1.754 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为和誉开曼17.54亿港元IPO提供法律服务

24 August 2021

Herbert Smith Freehills advises sponsors on Acotec Scientific’s HK$1.529 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为先瑞达医疗15.29亿港元IPO提供法律服务